About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e67.

Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e66.

Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e57.

CVD in CKD Patients: Heart–Kidney Team-Based Approach

Published:

07 December 2021

Citation:

European Cardiology Review 2021;16:e48.